Hospital Medicine Safety CQI
Contact:
Rozanne Darland
CQI Administrator
313-448-5573
rdarland@bcbsm.com
Blood clot, or venous thromboembolism, occurs for the first time in about 100 people per 100,000 each year in the United States. About one-third of patients with blood clots have pulmonary embolism while two-thirds have deep vein thrombosis1.
The Michigan Hospital Medicine Safety Consortium launched in October 2010. Initially, participants are focusing on improving the care of medical patients at risk for hospital-associated venous thromboembolism. Adverse events related to VTEs are common and problematic, leading to poor clinical outcomes and prolonged hospital stays. Hospitalists, due to their management of diverse groups of hospitalized patients and close interactions with hospital staff, are ideally positioned to champion efforts at preventing adverse events in hospitalized patients.
Goals
- Evaluate and understand current practice of pharmacologic blood clot prevention for high-risk medical patients.
- Implement improvement strategies and evaluate change over time.
- Identify, develop and implement systems-based strategies to improve overall rates of blood clot prevention in defined populations.
Results
- TBD
